Advisor Group Holdings, Inc. Lineage Cell Therapeutics, Inc. Transaction History

Advisor Group Holdings, Inc.

  • $42.1 Billion
  • Q1 2025

A detailed history of Advisor Group Holdings, Inc. transactions in Lineage Cell Therapeutics, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 97,252 shares of LCTX stock, worth $109,894. This represents 0.0% of its overall portfolio holdings.

Number of Shares
97,252
Previous 22,935 324.03%
Holding current value
$109,894
Previous $11,000 290.91%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025
BUY
$0.45 - $0.72 $33,442 - $53,508
74,317 Added 324.03%
97,252 $43,000
Q4 2024

Jun 06, 2025
SELL
$0.5 - $0.95 $20,258 - $38,490
-40,516 Reduced 41.66%
56,736 $28,000
Q4 2024

Feb 07, 2025
SELL
$0.5 - $0.95 $20,558 - $39,060
-41,116 Reduced 64.19%
22,935 $11,000
Q3 2024

Nov 13, 2024
BUY
$0.8 - $1.12 $13,529 - $18,941
16,912 Added 35.88%
64,051 $58,000
Q2 2024

Aug 13, 2024
BUY
$0.89 - $1.47 $40,096 - $66,226
45,052 Added 2158.7%
47,139 $47,000
Q1 2024

May 10, 2024
SELL
$0.86 - $1.48 $91 - $156
-106 Reduced 4.83%
2,087 $3,000
Q4 2023

Feb 12, 2024
SELL
$0.91 - $1.35 $40,201 - $59,640
-44,178 Reduced 95.27%
2,193 $2,000
Q3 2023

Nov 13, 2023
SELL
$1.16 - $1.53 $457 - $602
-394 Reduced 0.84%
46,371 $54,000
Q2 2023

Aug 21, 2023
SELL
$1.26 - $1.53 $6 - $7
-5 Reduced 0.01%
46,765 $65,000
Q2 2023

Aug 10, 2023
BUY
$1.26 - $1.53 $108 - $131
86 Added 0.18%
46,770 $65,000
Q4 2022

Feb 10, 2023
BUY
$1.02 - $1.5 $45,288 - $66,600
44,400 Added 1943.96%
46,684 $54,000
Q1 2022

May 04, 2022
SELL
$1.21 - $2.48 $107 - $220
-89 Reduced 3.75%
2,284 $3,000
Q3 2021

Nov 05, 2021
SELL
$2.26 - $2.86 $903 - $1,144
-400 Reduced 14.42%
2,373 $6,000
Q2 2021

Aug 02, 2021
SELL
$2.17 - $3.0 $6,776 - $9,369
-3,123 Reduced 52.97%
2,773 $13,000
Q1 2021

May 13, 2021
BUY
$1.77 - $3.1 $6,336 - $11,098
3,580 Added 154.58%
5,896 $13,000
Q4 2020

Feb 10, 2021
SELL
$0.95 - $1.83 $663 - $1,277
-698 Reduced 23.16%
2,316 $4,000
Q3 2020

Nov 12, 2020
BUY
$0.75 - $1.09 $14 - $20
19 Added 0.63%
3,014 $3,000
Q2 2020

Aug 14, 2020
BUY
$0.71 - $1.18 $95 - $158
134 Added 4.68%
2,995 $2,000
Q1 2020

May 18, 2020
BUY
$0.6 - $1.58 $1,716 - $4,520
2,861 New
2,861 $2,000

Others Institutions Holding LCTX

# of Institutions
139
Shares Held
108M
Call Options Held
8K
Put Options Held
3K
View Full List

About Lineage Cell Therapeutics, Inc.

LCTX Quotes by TradingView
  • Ticker LCTX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 169,755,008
  • Market Cap $192M
  • Description
  • Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, develops novel cell therapies for the treatment of degenerative diseases in the United States and internationally. The company develops OpRegen, a retinal pigment epithelium cell replacement therapy, which is in Phase I/IIa clinical trial for the treatment of the dry age-re...
More about LCTX
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email